Prenatal tests
NIPT and genetic screening in pregnancy: what to know
Your decision
At a glance
- Typical weeks
- From about week 10 of pregnancy. ACOG says it can be done up until delivery. Weeks on this page are completed weeks of pregnancy.
- What it is
- A blood test that looks at small pieces of DNA from the placenta in the pregnant person’s blood, to estimate the chance of certain chromosome conditions in the baby. Chromosomes are tiny packages in your cells that contain your genes, and these conditions are caused by missing or extra chromosomes. It screens; it does not diagnose.
- Routine or optional
- Optional, and your choice. ACOG’s January 2026 advisory says cell-free DNA screening should be routinely available to everyone who is pregnant.
- The blood draw and results
- A blood draw from a vein in the arm that takes a few minutes. ACOG says it takes about 1 week to get the results. Ask your lab or practice when to expect yours.
What it is
Cell-free DNA screening is a blood test of the pregnant person. It looks at small pieces of DNA that come from the placenta and are found in her blood, to estimate the chance of certain chromosome conditions in the baby.
The same test goes by several names, including NIPT (non-invasive prenatal testing) and NIPS (non-invasive prenatal screening). SMFM prefers “prenatal screening with cfDNA” (short for cell-free DNA), because the older name suggests that the test is diagnostic. SMFM adds that patients may be more familiar with the name NIPT.
It is a screening test, not a diagnostic test. It can show a higher or lower chance of a condition, and it cannot say for sure whether the baby has one. A diagnostic test is the kind that can say, with as much certainty as possible, whether the baby has a specific condition.
It mainly checks the chance of Down syndrome (trisomy 21), Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13). A trisomy is a condition with an extra chromosome.
ACOG’s January 2026 advisory rates cell-free DNA screening as the most sensitive and specific screening test for these three conditions. In plain words, compared with the other screening tests, it is the most likely to find one of them and the least likely to flag one that is not there.
Screening for sex chromosome conditions (a missing or extra X or Y chromosome) is a separate part. SMFM and ACOG say it should be made available as an “opt-in” choice after counseling, so you decide whether it is included. SMFM’s counseling points include that these conditions have variable and typically milder features than Down syndrome, trisomy 18 and trisomy 13, and that finding them before birth may result in improved outcomes. They also include that the screening has a higher chance of false-positive results, that a positive result can show an unexpected finding about the pregnant person, and that it may show the baby’s sex.
Other screening choices are first-trimester screening, which combines a blood test with an ultrasound called the nuchal translucency (NT) scan that measures the thickness of a space at the back of the baby’s neck, and the second-trimester quad test, a blood test that measures four different substances in the pregnant person’s blood. ACOG’s January 2026 advisory says these remain options if you prefer them after counseling, or when cell-free DNA cannot be offered. It also says screening with blood tests, the first-trimester ultrasound, or both can lead to findings that cell-free DNA may not detect, such as conditions in how the baby’s body is formed.
ACOG recommends an anatomy scan for every pregnancy, whichever screening you choose.
Diagnostic testing is a separate choice. Two diagnostic tests are chorionic villus sampling (CVS), which takes a small sample of tissue from the placenta, and amniocentesis, which takes a small amount of amniotic fluid, the fluid around the baby. ACOG says they are offered to everyone who is pregnant, including people with no risk factors, and that you can choose them instead of, or in addition to, screening. ACOG says the main benefit of diagnostic tests over screening is that they can detect all conditions caused by an extra chromosome and many other disorders in which chromosomes are missing or damaged, and that the main disadvantage is a very small chance of losing the pregnancy.
Carrier screening is a different test. It is done on the parents and looks at their genes, while cell-free DNA screening uses the pregnant person’s blood to estimate the chance of certain chromosome conditions in the baby.
When it happens
Cell-free DNA screening can be done from about week 10 of pregnancy. ACOG says it can be done up until delivery. Weeks on this page are completed weeks of pregnancy.
The test can only report a result when enough of the DNA in the pregnant person’s blood comes from the placenta. That share is higher later in pregnancy, which is why testing very early can lead to no result.
Certain prenatal tests can be done only at certain times in pregnancy. Ask your provider when the best time is for you.
To see where this fits among your other visits, read the prenatal appointment schedule.
What happens
- Before the test, ACOG and SMFM say people should have counseling, so they can decide whether to have cell-free DNA screening. SMFM says the provider who offers the test should understand its benefits, its limits and how well it performs, and be able to counsel on them. MedlinePlus says you may want to speak with a genetic counselor before you get tested.
- Ask your lab or office whether there are any instructions to follow before the blood draw.
- Blood is taken from a vein in the pregnant person’s arm. It takes a few minutes.
- The sample comes from the pregnant person only. No sample from the partner is needed.
- The lab then reports a result. ACOG says it takes about 1 week to get the results. MedlinePlus Genetics says whoever orders a genetic test, a doctor or a genetic counselor, can give its specific cost and time frame. Ask when you will get your result, and how and from whom you will hear it.
The blood draw carries no risk to the baby and very little risk to the pregnant person, such as a sting or a bruise.
SMFM says counseling before the test should cover cost, insurance coverage and how results will be returned, and its example script tells patients to understand the cost of the test before they take it. ACOG’s advisory lists lack of insurance coverage among the reasons cell-free DNA may not be offered. Ask your office and your insurer about cost and coverage before the test.
A genetic counselor can go through your family health history, help you choose tests and explain results. Genetic counseling is available in person, by phone and by video. The CDC points to the National Society of Genetic Counselors directory to find a counselor, and a commentary on ACOG’s website by one doctor says to ask your ob-gyn for a referral if you are interested.
Risks and limits
- False positives and false negatives
- A false positive shows a problem that is not there. A false negative misses one that is. Any prenatal screening test can give either, and ACOG says your provider can give you the rates for each test.
- Why a result can be wrong
- The test reads DNA from the placenta. It is usually, but not always, the same as the baby’s, so a positive result can be right about the placenta and wrong about the baby. SMFM also lists other reasons for a false positive, such as a twin pregnancy that did not continue, differences in the pregnant person’s own chromosomes, and technical errors.
- How likely a positive result is to be right
- It depends on how common the condition is among people like you. ACOG says it depends on how often the condition occurs in a group similar to you. In a group where the condition is less common, a positive result is more likely to be a false positive than in a group where the condition is more common. SMFM says the chance rises with age for Down syndrome, trisomy 18 and trisomy 13. In April 2022 the FDA said it also depends on how rare the condition is.
- No result
- Sometimes the lab cannot report a result, for example when there is too little DNA from the placenta in the sample.
- What it does not check
- ACOG’s infographic says it does not test for all types of chromosomal disorders, or for many other chromosomal and genetic disorders. SMFM says it does not screen for all possible genetic conditions.
- Neural tube defects
- ACOG’s infographic lists neural tube defects (defects of the baby’s brain and spine, such as spina bifida) among the conditions it does not screen for. ACOG says that if you have cell-free DNA screening, a blood test or an ultrasound exam should be offered to screen for them and for other conditions. Ask your provider whether a blood test for AFP (a protein made mostly by the baby, often tested as part of the quad screen), the anatomy ultrasound, or both make sense.
- Extra conditions some labs add
- ACOG’s January 2026 advisory does not recommend routine cell-free DNA screening for microdeletion conditions (small missing pieces of a chromosome) in the general population, and says people who want information about these should be offered diagnostic testing instead. Some labs also offer other tests, such as genome-wide checks (checks across all of the chromosomes) for large missing or extra pieces of chromosomes. The advisory does not recommend routine use of these either. Ask what the test your lab runs includes.
- A finding about the pregnant person
- SMFM says results that do not fit a chromosome condition in the baby can sometimes point to a health condition in the pregnant person, which would need further evaluation. SMFM calls this an “unexpected maternal result” and says it should be discussed before testing.
- More than one baby, a transplant or donor eggs
- If you are expecting twins or more, ask your provider what applies. ACOG and SMFM say cell-free DNA is an option for Down syndrome, trisomy 18 and trisomy 13 in twin pregnancies, and do not recommend it for pregnancies with three or more babies, because of a lack of data. MedlinePlus, on a page dated March 2024, says cell-free DNA screenings are not as accurate if you are pregnant with more than one baby. SMFM says people who have had a transplant, or whose pregnancy was achieved with donor eggs, should have genetic counseling to discuss the details of the screening. ACOG’s advisory lists a maternal organ transplant or stem cell therapy among the situations when cell-free DNA may not be offered.
ACOG’s infographic calls cell-free DNA screening a very good screening test for common chromosomal disorders, with limits. A negative result does not rule out a chromosomal disorder or other disorders the test does not check for, and a positive result needs a diagnostic test to show whether the baby is truly affected. SMFM says false positives are less common with cell-free DNA than with traditional blood or ultrasound screening.
In April 2022 the FDA warned patients and health care providers that genetic non-invasive prenatal screening tests (NIPS, also called NIPT) can give false results, such as reporting a genetic condition when the baby does not actually have one. The FDA said they are screening tests, not diagnostic tests.
Your results
Cell-free DNA screening gives a higher chance or a lower chance. It does not give a “yes” or a “no”. Depending on the lab, a report may use words such as “positive” or “high risk”. SMFM notes that wording like this can wrongly suggest a diagnosis. It stands for a higher chance.
SMFM says counseling before the test should cover the possible outcomes, which may be a positive result, an inconclusive result or an unexpected result. Any of them may need further testing, for the baby or for the pregnant person.
- If the result is a higher chance (positive), ACOG says it should be followed by genetic counseling, a detailed anatomy ultrasound and a recommendation for diagnostic testing with CVS or amniocentesis. You can also choose not to have more testing.
- If the lab cannot report a result, ACOG’s infographic says you should receive genetic counseling, and that an ultrasound exam and diagnostic testing should be offered, because the chance of a chromosomal disorder is increased. SMFM says a patient may choose to repeat the blood draw instead of having diagnostic testing, which may depend on several factors, including the ultrasound findings and how far along the pregnancy is, and that a patient may not wish to delay definite information.
- SMFM advises against basing decisions about the pregnancy only on a cell-free DNA screening result. In April 2022 the FDA advised patients to go over screening results with a genetic counselor or another health care provider before making any decisions about the pregnancy.
- After testing, your obstetrician or a genetic counselor can explain what a result means and help you decide the next steps. The CDC says counseling after testing can also help you deal with emotional concerns, and can refer you to other health care providers and to advocacy and support groups.
A result can tell you
- A higher chance of Down syndrome, trisomy 18 or trisomy 13 than the general population has. This is sometimes called a positive result.
- A lower chance of these conditions than the general population has. This is sometimes called a negative result.
A result cannot tell you
- For certain whether the baby has a condition. ACOG says a higher-chance result does not mean that the baby definitely has the condition.
- That the baby does not have a condition. ACOG says a lower-chance result does not rule out the condition.
- Anything about conditions the test does not check for. ACOG’s infographic says it does not test for all types of chromosomal disorders, or for many other chromosomal and genetic disorders.
Questions to ask your provider or a genetic counselor
- What does this test look for, and what does it not look for? Does it include screening for sex chromosome conditions or other extras that we can choose?
- What are our other choices, including other screening tests and diagnostic testing?
- How well does this test work for someone like us, and what would a false positive or a false negative mean?
- Could the result tell us something about the pregnant person’s own health, and how would that be handled?
- What happens if the lab cannot give a result?
- What would the next steps be after a higher-chance result?
- What will it cost, and will insurance cover it?
- When and how will we get the result, and from whom? Can we talk with a genetic counselor first?
What the partner does
- ACOG says a partner can be supportive by going with the pregnant person to prenatal care appointments. Ask the office whether you can come to the counseling visit, join by phone or video, or be there when results are shared. The CDC says genetic counseling is available in person, by phone and by video.
- The blood sample comes from the pregnant person only. No sample from you is needed.
- Before the test, talk together about how each of you thinks about the information, what you would each want to know, and when.
- Talk through the three questions from that commentary together: what are your risk factors, how much do you want to know, and what would you do with the information? ACOG says there is no right or wrong answer.
- Look at the choices together before the visit, including the choice to decline some or all of the screening. Listen to each other, and support the choice your partner makes with their provider.
- Write your questions down together, using the list above. Agree beforehand how you will hear the result (a call, the patient portal or a visit) and who will be with your partner when it arrives. While you wait, plan something low-key and keep the office’s phone number handy.
- If a result raises questions, take notes together, ask the provider or counselor to repeat anything that is unclear, and ask who to call with follow-up questions. If either of you wants support, ask about a genetic counselor and about support groups.
How involved you are is for the two of you to work out. Ask your partner what would help most.
Questions people ask
What is the NIPT test?
NIPT, also called cell-free DNA screening, is a blood test that looks at small pieces of DNA from the placenta in the pregnant person’s blood. It estimates the chance of certain chromosome conditions in the baby, mainly Down syndrome, trisomy 18 and trisomy 13. It is a screening test, not a diagnosis. It can be done from about week 10, and it is your choice.
How accurate is the NIPT test?
Cell-free DNA screening has limits. It can give false positives and false negatives, and a positive result needs a diagnostic test to show whether the baby is truly affected. ACOG’s infographic also calls it a very good screening test for common chromosomal disorders, and its January 2026 advisory rates it as the most sensitive and specific screening test for Down syndrome, trisomy 18 and trisomy 13.
What does a positive or high-risk NIPT result mean?
A positive or high-risk result means a higher chance of the condition than in the general population. ACOG says it does not mean the baby definitely has it, and that it should be followed by genetic counseling, a detailed ultrasound and a recommendation for diagnostic testing. You can choose not to have more testing. SMFM advises against basing decisions about the pregnancy on the screening result alone.
Can NIPT tell the baby’s sex?
Mayo Clinic says cell-free DNA screening can provide information about a baby’s sex. SMFM says the nonmedical use of the test solely to find out the sex is not recommended, and notes that knowing the sex has medical benefits for families at risk of certain inherited conditions in male babies. SMFM and ACOG say screening for sex chromosome conditions is an opt-in choice after counseling, so you decide whether it is included.
Do I need NIPT, or is it optional?
It is optional. ACOG’s January 2026 advisory says cell-free DNA screening should be routinely available to everyone who is pregnant. ACOG and SMFM say that after counseling every patient can have it, decline it, or decline parts of it. ACOG says it is your choice, and there is no right or wrong answer. Talk it through with your provider.
What is the difference between NIPT and amniocentesis?
NIPT is a blood draw that shows a higher or lower chance and cannot give a certain answer. Amniocentesis, a diagnostic test, takes a small amount of amniotic fluid with a thin needle and can tell, with as much certainty as possible, whether the baby has the condition tested. ACOG says the main disadvantage of diagnostic testing is a very small chance of pregnancy loss. You can choose either, or both.
In the app
Sources
- Screening for Fetal Chromosomal Abnormalities (Practice Advisory) (opens in a new tab)ACOG · January 2026
- SMFM Consult Series #74: Cell-free DNA screening for aneuploidies: updated guidance (opens in a new tab)Society for Maternal-Fetal Medicine (endorsed by ACOG) · November 2025
- Cell-Free DNA Prenatal Screening Test (infographic PFSI008) (opens in a new tab)ACOG · Updated October 2025; page dated October 2025
- Prenatal Genetic Screening Tests (FAQ165) (opens in a new tab)ACOG · Updated October 2020; page dated October 2025
- Prenatal Genetic Diagnostic Tests (FAQ164) (opens in a new tab)ACOG · Updated December 2022; page dated April 2026
- Routine Tests During Pregnancy (FAQ133) (opens in a new tab)ACOG · Updated April 2024; page dated January 2026
- Genetic Disorders and Pregnancy (FAQ094) (opens in a new tab)ACOG · Updated May 2023; page dated April 2025
- 3 Questions to Ask Yourself Before Getting Prenatal Genetic Testing (opens in a new tab)ACOG · Published October 2020; page dated August 2026
- A Partner’s Guide to Pregnancy (FAQ032) (opens in a new tab)ACOG · Updated January 2023; page dated February 2025
- FDA safety communication, April 19, 2022 (archived copy) (opens in a new tab)FDA · April 19, 2022
- Prenatal Cell-Free DNA Screening (opens in a new tab)MedlinePlus (NIH) · March 19, 2024
- Down Syndrome Tests (opens in a new tab)MedlinePlus (NIH) · January 20, 2026
- What is noninvasive prenatal testing (NIPT) and what disorders can it screen for? (opens in a new tab)MedlinePlus Genetics (NIH) · July 28, 2021
- How are genetic screening tests different from genetic diagnostic tests? (opens in a new tab)MedlinePlus Genetics (NIH) · July 28, 2021
- What is the cost of genetic testing, and how long does it take to get the results? (opens in a new tab)MedlinePlus Genetics (NIH) · July 28, 2021
- Alpha-Fetoprotein (AFP) Test (opens in a new tab)MedlinePlus (NIH) · December 19, 2024
- Spina Bifida: About (opens in a new tab)CDC · Updated September 9, 2026; page dated September 10, 2026
- Genetic Counseling (opens in a new tab)CDC · January 31, 2025
- Prenatal testing: Is it right for me? (opens in a new tab)Mayo Clinic · August 6, 2024
Sources last checked:
Medical disclaimer: General info, not medical advice. Your OB, midwife or pediatrician knows your situation; check with them. If something feels wrong, don't wait on an app. Call your provider, or 911 in an emergency. Read the full medical disclaimer